QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.73 (-0.77%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.95 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-2.06%)
GE   106.30 (+0.22%)
DIS   91.93 (-0.65%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NYSE:RMAX

RE/MAX (RMAX) Stock Forecast, Price & News

$19.11
-0.30 (-1.55%)
(As of 04:33 PM ET)
Compare
Today's Range
$19.03
$19.33
50-Day Range
$17.92
$19.63
52-Week Range
$16.78
$28.25
Volume
55,726 shs
Average Volume
118,274 shs
Market Capitalization
$346.27 million
P/E Ratio
147.00
Dividend Yield
4.81%
Price Target
$24.50

RE/MAX MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
28.0% Upside
$24.50 Price Target
Short Interest
Healthy
2.91% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.61mentions of RE/MAX in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
$2.76 M Bought Last Quarter
Proj. Earnings Growth
19.15%
From $0.94 to $1.12 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.72 out of 5 stars

Finance Sector

217th out of 862 stocks

Real Estate Agents & Managers Industry

2nd out of 14 stocks


RMAX stock logo

About RE/MAX (NYSE:RMAX) Stock

RE/MAX Holdings, Inc. engages in the provision of real estate franchise services through its subsidiaries. It operates through the following segments: Real Estate, Mortgage, Marketing Funds, and Other. The Real Estate segment is comprised of the Company's owned and independent global franchising operations under the RE/MAX brand name and technology and data subscription for Gadberry and the First app. The Mortgage segment is comprised of the firm's mortgage brokerage franchising operations under the Motto Mortgage brand name and mortgage loan processing services and licensed software under the wemlo brand. The Marketing Funds segment is involved in the operations of the marketing campaigns designed to build and maintain brand awareness and the development and operation of agent marketing technology. The Other segment focuses on the legacy operations of the booj Platform. The company was founded by David L. Liniger and Gail A. Liniger in 1973 and is headquartered in Denver, CO.

Receive RMAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RE/MAX and its competitors with MarketBeat's FREE daily newsletter.

RMAX Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Get MarketBeat All Access Free for 30 Days
MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports and much more. Try it free for 30 days.
RE/MAX Holdings Inc. Cl A
Analyst Ratings for RE/MAX Hldgs
RE/MAX Canada parts ways with Little Oak Realty
RE/MAX Hldgs: Dividend Insights
See More Headlines

RMAX Price History

RMAX Company Calendar

Ex-Dividend for 3/22 Dividend
3/07/2023
Dividend Payable
3/22/2023
Last Earnings
5/05/2023
Ex-Dividend for 5/31 Dividend
5/16/2023
Dividend Payable
5/31/2023
Today
6/09/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate agents & managers
Sub-Industry
N/A
Sector
Finance
Employees
639
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$24.50
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$21.00
Forecasted Upside/Downside
+28.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$6.11 million
Pretax Margin
3.94%

Debt

Sales & Book Value

Annual Sales
$353.39 million
Cash Flow
$4.82 per share
Book Value
$1.77 per share

Miscellaneous

Free Float
17,288,000
Market Cap
$346.09 million
Optionable
Optionable
Beta
1.48

Key Executives

  • Stephen P. Joyce
    Chief Executive Officer & Director
  • Nicholas R. Bailey
    President
  • Serene M. Smith
    Chief Operating Officer & Chief of Staff
  • Karri R. Callahan
    Chief Financial Officer
  • Jamie Barcia
    Vice President-IT, Infrastructure & Operations













RMAX Stock - Frequently Asked Questions

Should I buy or sell RE/MAX stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RE/MAX in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RMAX shares.
View RMAX analyst ratings
or view top-rated stocks.

What is RE/MAX's stock price forecast for 2023?

2 Wall Street research analysts have issued 12-month price targets for RE/MAX's stock. Their RMAX share price forecasts range from $21.00 to $28.00. On average, they expect the company's share price to reach $24.50 in the next twelve months. This suggests a possible upside of 28.3% from the stock's current price.
View analysts price targets for RMAX
or view top-rated stocks among Wall Street analysts.

How have RMAX shares performed in 2023?

RE/MAX's stock was trading at $18.64 on January 1st, 2023. Since then, RMAX shares have increased by 2.5% and is now trading at $19.10.
View the best growth stocks for 2023 here
.

When is RE/MAX's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our RMAX earnings forecast
.

How were RE/MAX's earnings last quarter?

RE/MAX Holdings, Inc. (NYSE:RMAX) issued its quarterly earnings data on Friday, May, 5th. The financial services provider reported $0.26 EPS for the quarter, hitting the consensus estimate of $0.26. The financial services provider earned $85.40 million during the quarter, compared to the consensus estimate of $83.91 million. RE/MAX had a trailing twelve-month return on equity of 103.70% and a net margin of 0.78%. The business's quarterly revenue was down 6.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.37 EPS.

How often does RE/MAX pay dividends? What is the dividend yield for RE/MAX?

RE/MAX announced a quarterly dividend on Wednesday, May 3rd. Stockholders of record on Wednesday, May 17th will be given a dividend of $0.23 per share on Wednesday, May 31st. This represents a $0.92 annualized dividend and a dividend yield of 4.82%. The ex-dividend date of this dividend is Tuesday, May 16th.
Read our dividend analysis for RMAX
.

Is RE/MAX a good dividend stock?

RE/MAX (NYSE:RMAX) pays an annual dividend of $0.92 per share and currently has a dividend yield of 4.69%. RMAX has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 707.69%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, RMAX will have a dividend payout ratio of 82.14% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for RMAX.

What guidance has RE/MAX issued on next quarter's earnings?

RE/MAX issued an update on its second quarter 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $79.00 million-$84.00 million, compared to the consensus revenue estimate of $83.46 million.

What is Adam Contos' approval rating as RE/MAX's CEO?

84 employees have rated RE/MAX Chief Executive Officer Adam Contos on Glassdoor.com. Adam Contos has an approval rating of 91% among the company's employees. This puts Adam Contos in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RE/MAX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RE/MAX investors own include Weyerhaeuser (WY), JPMorgan Chase & Co. (JPM), Ambarella (AMBA), Bank of America (BAC), Citigroup (C), Cisco Systems (CSCO), eXp World (EXPI), Marathon Petroleum (MPC), Starbucks (SBUX) and Simon Property Group (SPG).

What is RE/MAX's stock symbol?

RE/MAX trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMAX."

Who are RE/MAX's major shareholders?

RE/MAX's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (17.28%), Magnolia Group LLC (14.34%), Dimensional Fund Advisors LP (7.90%), Renaissance Technologies LLC (4.95%), State Street Corp (3.86%) and Confluence Investment Management LLC (3.56%). Insiders that own company stock include Adam K Peterson, Adam W Grosshans, Brett A Ritchie and Ronald E Harrison.
View institutional ownership trends
.

How do I buy shares of RE/MAX?

Shares of RMAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RE/MAX's stock price today?

One share of RMAX stock can currently be purchased for approximately $19.10.

How much money does RE/MAX make?

RE/MAX (NYSE:RMAX) has a market capitalization of $346.09 million and generates $353.39 million in revenue each year. The financial services provider earns $6.11 million in net income (profit) each year or $0.13 on an earnings per share basis.

How many employees does RE/MAX have?

The company employs 639 workers across the globe.

How can I contact RE/MAX?

RE/MAX's mailing address is 5075 SOUTH SYRACUSE STREET, DENVER CO, 80237. The official website for the company is www.remax.com. The financial services provider can be reached via phone at (303) 770-5531, via email at investorrelations@remax.com, or via fax at 303-796-3599.

This page (NYSE:RMAX) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -